Tutor Perini (NYSE:TPC) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Wednesday.
According to Zacks, “Tutor Perini Corporation provides diversified general contracting, construction management and design-build services to private clients and public agencies worldwide. The company operates in four segments: Civil, Building, Specialty Contractors, and Management Services. The Civil segment engages in public works construction activities and the repair, replacement, and reconstruction of infrastructure. The Building segment offers services in specialized building markets, including hospitality and gaming, transportation, healthcare, municipal offices, sports and entertainment, education, correctional facilities, biotech, pharmaceutical, industrial, and high technology. The Specialty Contractors segment provides plumbing, HVAC, electrical, mechanical, and concrete services for the industrial, commercial, hospitality and gaming, and transportation markets. The Management Services segment offers construction and design-build services to the U.S. military and government agencies, and multi-national corporations. “
Top 5 High Tech Stocks To Buy For 2021: Armada Hoffler Properties, Inc.(AHH)
References to “we,” “our,” “us” and “our company” refer to Armada Hoffler Properties, Inc., a Maryland corporation, together with our consolidated subsidiaries, including Armada Hoffler, L.P., a Virginia limited partnership (the “Operating Partnership”), of which we are the sole general partner.
We are a full service real estate company with extensive experience developing, building, owning and managing high-quality, institutional-grade office, retail and multifamily properties in attractive markets throughout the Mid-Atlantic United States. In addition to the ownership of our operating property portfolio, we develop and build properties for our own account and through joint ventures between us and unaffiliated partners. We also provide general contracting services to third parties. Advisors’ Opinion:
- [By Joseph Griffin]
Martingale Asset Management L P lowered its position in Armada Hoffler Properties Inc (NYSE:AHH) by 12.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 94,910 shares of the real estate investment trust’s stock after selling 13,100 shares during the period. Martingale Asset Management L P owned approximately 0.19% of Armada Hoffler Properties worth $1,415,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
- [By Stephan Byrd]
Principal Financial Group Inc. increased its holdings in Armada Hoffler Properties Inc (NYSE:AHH) by 2.9% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 345,684 shares of the real estate investment trust’s stock after purchasing an additional 9,584 shares during the period. Principal Financial Group Inc.’s holdings in Armada Hoffler Properties were worth $4,732,000 as of its most recent filing with the SEC.
- [By Lee Jackson]
This is one of the higher yielding plays, and the stock has performed well this year. Armada Hoffler Properties Inc. (NYSE: AHH) is a vertically integrated, self-managed REIT developing, building, acquiring and managing high-quality, institutional-grade office, retail and multifamily properties.
- [By Joseph Griffin]
Armada Hoffler Properties (NYSE:AHH) had its price target raised by Bank of America from $15.50 to $16.75 in a report released on Monday. The firm currently has a “buy” rating on the real estate investment trust’s stock. Bank of America’s price objective points to a potential upside of 7.44% from the stock’s previous close.
Top 5 High Tech Stocks To Buy For 2021: LyondellBasell Industries NV(LYB)
LyondellBasell Industries N.V. manufacturers and sells chemicals and polymers, refines crude oil, produces gasoline blending components, and develops and licenses technologies for production of polymers. The company?s Olefins and Polyolefins segment offers olefins, including ethylene, propylene, and butadiene; aromatics, such as benzene and toluene; polyolefins, which comprise polypropylene (PP), high-density polyethylene, low-density polyethylene, and linear low-density polyethylene; specialty polyolefins, including catalloy process resins, PP compounds, and polybutene-1 resins; and ethylene derivatives, which comprise ethanol. Its Intermediates and Derivatives segment provides propylene oxide (PO); PO co-products, including styrene monomers and TBA derivative isobutylene; PO derivatives, such as propylene glycol, propylene glycol ethers, and butanediol; acetyls, such as methanol, acetic acid, and vinyl acetate monomers; ethylene derivatives, which comprise ethylene oxide , ethylene glycol, and ethylene glycol ethers; and flavor and fragrance chemicals. The company?s Refining and Oxyfuels segment offers gasoline and components, ultra low sulfur diesel, jet fuel, and lube oils; diesel, feedstock, fuel oil, gasoline, and bitumen; and gasoline blending components, including methyl tertiary butyl ether, ethyl tertiary butyl ether, and alkylate. Its Technology segment develops and licenses polyolefin and other process technologies. This segment also develops, manufactures, and sells polyolefin catalysts, as well as provides technology services, which comprise safety reviews, training and start-up assistance, engineering services for process and product improvements, and manufacturing troubleshooting. LyondellBasell Industries N.V. has operations in the Americas, Europe, Asia, and internationally. The company was founded in 2005 and is based in Rotterdam, Netherlands. LyondellBasell Industries N.V. is a subsidiary of Prochemie GmbH.
- [By Bob Ciura]
Combined with the current 2.2% dividend yield and 5% earnings growth estimate, we see total annual returns of 14.6% in the coming years.
LyondellBasell Industries N.V. (LYB) Source: Flagmania / Shutterstock.com
Our final stock is LyondellBasell, a chemical company that operates primarily in the US and Europe. The company produce a wide variety of chemicals and plastics focused on goals such as water purity, improved functionality of electronics and appliances, food safety, fuel efficiency of internal combustion engines and more.
- [By Josh Enomoto]
Still, Prudential executives recently stated that the impact of the coronavirus was “beginning to moderate.” Further, people with insurance are likely to be vaccinated, thus mitigating disruptive occurrences.
Dividend Stocks: LyondellBasell Industries (LYB)
Top 5 High Tech Stocks To Buy For 2021: Carriage Services, Inc.(CSV)
Carriage Services, Inc. provides death care services and merchandise in the United States. It operates through two segments, Funeral Home Operations and Cemetery Operations. The Funeral Home Operations segment offers burial and cremation services, as well as related merchandise to meet a familys death care needs, including consultation; the removal and preparation of remains; the sale of caskets, urns, and related funeral merchandise; the use of funeral home facilities for visitation and services; and transportation services. The Cemetery Operations segment provides products and services, such as interment services; the rights to interment in cemetery sites comprising grave sites, mausoleum crypts, and niches; and related cemetery merchandise, including memorials and vaults. As of February 9, 2016, the company operated 167 funeral homes in 27 states; and 32 cemeteries in 11 states. Carriage Services, Inc. was founded in 1991 and is headquartered in Houston, Texas.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Carriage Services (CSV)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Carriage Services, Inc. (NYSE:CSV) insider Shawn R. Phillips sold 6,500 shares of Carriage Services stock in a transaction that occurred on Thursday, September 27th. The shares were sold at an average price of $21.65, for a total transaction of $140,725.00. Following the transaction, the insider now owns 106,946 shares of the company’s stock, valued at $2,315,380.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Top 5 High Tech Stocks To Buy For 2021: Energy XXI Ltd.(EXXI)
Energy XXI Ltd engages in the acquisition, exploration, development, and operation of oil and natural gas properties onshore in Louisiana and Texas, and on the Gulf of Mexico. As of June 30, 2015, the company had net proved reserves of 183.5 million barrels of oil equivalent. It operated or had an interest in 567 gross producing wells on 388,199 net developed acres, including interests in 52 producing fields. The company was founded in 2005 and is based in Houston, Texas.
- [By Dan Caplinger]
The stock market was mostly higher on Monday, with market participants celebrating favorable economic news on the consumer front and looking forward to another round of positive earnings reports when third-quarter earnings season starts early next month. Tax cuts have helped corporate earnings throughout 2018, and that’s generally helped to lift the overall market. Yet even with several major market benchmarks at or near record levels, some stocks weren’t able to participate in the gains today. Brown-Forman (NYSE:BF-B), Acorda Therapeutics (NASDAQ:ACOR), and Energy XXI Gulf Coast (NASDAQ:EXXI) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.
Top 5 High Tech Stocks To Buy For 2021: Genomic Health, Inc.(GHDX)
Genomic Health, Inc., incorporated on August 22, 2000, is a healthcare company, which provides genomic-based diagnostic tests for the treatment of early stage cancer. The Company offers its Oncotype DX tests as a clinical laboratory service, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score for invasive breast cancer and colon cancer, a DCIS Score for ductal carcinoma in situ (DCIS) and a Genomic Prostate Score (GPS) for prostate cancer.
The Company’s Oncotype DX tests analyze the expression levels of various genes across various biological pathways. Its offerings also include Oncotype DX Breast Cancer Test, Oncotype DX Colon Cancer Test and Oncotype DX Prostate Cancer Test. The Oncotype DX breast, colon and prostate cancer tests analyze various genes and are based on its Oncotype DX RT-PCR platform. The Company offers its services and products through its Oncotype IQ Genomic Intelligence Platform. Its Oncotype IQ Genomic Intelligence Platform product pipeline also includes products for tumor monitoring under its Oncotype TRACK for various cancer types. The Company offers its testing services through its clinical reference laboratory located in Redwood City.
Oncotype DX Tests
The Company’s Oncotype DX tests utilize quantitative genomic analysis known as reverse transcription polymerase chain reaction (RT-PCR), in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. Its diagnostic approach correlates gene expression to clinical outcomes and provides an individualized analysis of each patient’s tumor. The Company’s technologies allow it to analyze tumor tissue samples in its clinical reference laboratory and provide physicians with genomic information specific to the patient’s tumor. The Company analyzes tissues that are handled, processed and stored un! der routine clinical pathology laboratory practices.
The Company competes with Roche Holding, Ltd, Siemens AG, Guardant Health, Johnson & Johnson, NanoString Technologies Inc., BioTheranostics, Sividon Diagnostics, Myriad Genetics Inc., NeoGenomics Laboratories, GenomeDx Biosciences Inc., Agendia Inc., Hologic Inc., Novartis AG, Qiagen N.V., Foundation Medicine, Grail, MDxHealth, Natera Inc., Trovagene Inc., Laboratory Corporation of America Holdings and Quest Diagnostics Incorporated.
- [By Shane Hupp]
Genomic Health (NASDAQ:GHDX) was downgraded by investment analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday.
- [By Maxx Chatsko]
Despite all the progress, Invitae is still the least mature business among its publicly traded peers, including Genomic Health (NASDAQ:GHDX) and Myriad Genetics (NASDAQ:MYGN). Here’s how it compares to its closest competitors:
- [By Motley Fool Transcription]
Genomic Health, Inc. (NASDAQ:GHDX) Q4 2018 Earnings Conference Call February 20, 2019, 4:30 p.m. ET
Prepared Remarks Questions and Answers Call Participants